Govt panel recommends EUA for Biological E's Corbevax for 5 to 11 years

Centre panel recommends emergency use authorisation for Biological E's Corbevax for 5-11 age group

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12 to 17 years age group.

eua: Covid vaccine: Govt panel recommends EUA for Biological E's Corbevax for 5 to 11 years

India News: NEW DELHI: Drug regulator’s expert panel on Covid vaccines has recommended granting emergency use authorisation to Biological E's Corbevax for use in .

Government panel clears restricted emergency use of Corbevax for 5-11 years

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years.

COVID-19 Vaccine Update: Subject Expert Panel Recommends Corbevax Vaccine for Children Aged 5-11

Dr Saxena said that the Corbevax vaccine has been found to have high levels of effectiveness as it uses a process that has already been tried and tested with another vaccine also given to children. The Corbevax is currently being administered to children in the age group of 12-14. COVID-19 Vaccine Update: Subject Expert Panel Recommends Corbevax Vaccine for Children Aged 5-11.

Govt panel recommends EUA for Biological E's Corbevax for 5 to 11 years

New Delhi, Apr 21 (PTI) An expert panel of India’s central drug authority has recommended granting emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for children in the five to 11 years age group, official sources said on Thursday. The Subject Expert Committee on COVID-19 of the CDSCO has, however, sought more data from […]

Govt panel recommends EUA for Biological E's Corbevax for 5 to 11 years

An expert panel of India's central drug authority has recommended granting emergency use authorisation for Biological E's COVID-19 vaccine Corbevax for children in the five to 11 years age group, official sources said on Thursday.